Drug Classification · Questions 1–6
Identify the pharmacological class or categorical label for each drug or receptor. Vocabulary preparation is sufficient to answer every question in this section.
Question 1
Metoprolol is classified as which type of beta-blocker?
Correct Answer
A) Cardioselective
Rationale
Metoprolol is classified as a cardioselective beta-blocker.
Question 2
Propranolol is classified as which type of beta-blocker?
Correct Answer
B) Non-selective
Rationale
Propranolol is classified as a non-selective beta-blocker, blocking beta-1 and beta-2 receptors equally.
Question 3
Carvedilol is classified as a beta-blocker with which additional property?
Correct Answer
A) Added alpha-1 blockade
Rationale
Carvedilol is classified as a beta-blocker with added alpha-1 blockade, providing additional peripheral vasodilation and afterload reduction.
Question 4
Nebivolol is classified as a beta-blocker with which additional property?
Correct Answer
C) Nitric oxide-mediated vasodilation
Rationale
Nebivolol is classified as a beta-blocker with nitric oxide-mediated vasodilation, producing less peripheral vasoconstriction than typical beta-blockers.
Question 5
Bisoprolol is classified as which type of beta-blocker?
Correct Answer
B) Cardioselective
Rationale
Bisoprolol is classified as a cardioselective beta-blocker.
Question 6
Beta-1 receptors are classified as predominantly located in which tissue?
Correct Answer
D) Cardiac tissue
Rationale
Beta-1 receptors are classified as predominantly located in cardiac tissue, including the sinoatrial node, atrioventricular node, and ventricular muscle.
Core Pharmacology · Questions 7–14
Apply your understanding of drug mechanisms, pharmacokinetics, and adverse effects. Each question requires one reasoning step.
Question 7
Why does beta-1 receptor blockade reduce myocardial oxygen demand?
Correct Answer
A) It lowers heart rate and contractility, the two factors beta-1 blockade directly controls
Rationale
Beta-1 blockade in the sinoatrial node slows heart rate, while beta-1 blockade in the ventricular myocardium reduces contractility. Both effects lower myocardial oxygen demand, with heart rate reduction being the dominant contributor.
Question 8
Beyond lowering oxygen demand, by which mechanism does beta-1 blockade also improve myocardial oxygen supply?
Correct Answer
C) A slower heart rate lengthens the diastolic interval, increasing the time available for coronary filling
Rationale
Coronary blood flow to the subendocardium occurs predominantly during diastole, since systolic compression of the coronary microvasculature limits flow during contraction. A slower heart rate from beta-1 blockade lengthens the diastolic interval, increasing the time available for coronary filling.
Question 9
Why are beta-blockers commonly combined with nitrates or dihydropyridine calcium channel blockers in antianginal therapy?
Correct Answer
B) Beta-blockers blunt the reflex increase in heart rate that these vasodilating agents would otherwise trigger
Rationale
Both nitrates and dihydropyridine calcium channel blockers lower blood pressure, which triggers a baroreceptor-mediated reflex increase in heart rate that partially offsets their anti-ischemic benefit. Beta-blockers prevent this reflex from raising heart rate, which is the central rationale for the combination.
Question 10
Why do non-selective beta-blockers cause bronchoconstriction?
Correct Answer
D) They block beta-2 receptors in bronchial smooth muscle, removing a bronchodilatory influence
Rationale
Beta-2 receptors in bronchial smooth muscle normally promote bronchodilation. Non-selective beta-blockers block these receptors along with beta-1 receptors, removing this bronchodilatory influence and producing bronchoconstriction.
Question 11
Why can cardioselective beta-blockers begin to block beta-2 receptors when given at high doses?
Correct Answer
A) Cardioselectivity is a relative rather than absolute property, and higher concentrations overcome the preferential beta-1 binding
Rationale
Cardioselective agents preferentially block beta-1 receptors over beta-2 receptors at standard doses, but this selectivity is relative rather than absolute. At high enough doses, cardioselective agents lose their selectivity and begin to block beta-2 receptors as well.
Question 12
Why does abruptly stopping a beta-blocker produce a rebound withdrawal syndrome in a patient with coronary artery disease?
Correct Answer
C) Chronic blockade causes receptor upregulation, and stopping abruptly exposes this enlarged, more sensitive receptor population to normal catecholamines
Rationale
Chronic beta-receptor blockade causes the body to compensate by increasing the number and sensitivity of beta-adrenergic receptors. If the beta-blocker is stopped abruptly, this enlarged, more sensitive receptor population is suddenly exposed to normal circulating catecholamines, producing an exaggerated sympathetic response.
Question 13
Why are beta-blockers contraindicated in vasospastic angina?
Correct Answer
B) Beta-2 blockade removes a normal coronary vasodilatory influence, leaving alpha-1-mediated vasoconstriction unopposed
Rationale
Blocking beta-2 receptors removes a normal coronary vasodilatory influence, leaving alpha-1-mediated vasoconstriction unopposed. In vasospastic angina this can precipitate or worsen spasm, and the effect applies to all beta-blockers, including cardioselective agents at typical doses.
Question 14
Why is acute initiation of a beta-blocker dangerous in decompensated heart failure, even though chronic, stable heart failure with reduced ejection fraction is an indication for careful beta-blocker initiation?
Correct Answer
D) The acute negative inotropic effect of beta-blockade further worsens hemodynamics in a heart that is not yet stable and compensated
Rationale
In acute decompensated heart failure, the heart is hemodynamically unstable, and the acute negative inotropic effect of beta-blockade worsens this instability. In chronic, stable heart failure with reduced ejection fraction, carefully initiated and slowly uptitrated beta-blockade is part of standard therapy because the heart has had time to compensate.
Clinical Correlations · Questions 15–18
Apply pharmacological knowledge to clinical scenarios. Each vignette presents a patient situation; the question tests mechanism of action or drug selection.
Question 15
A 60-year-old man with stable exertional angina is started on metoprolol. Over the following weeks, he reports fewer episodes of chest discomfort with exertion. Which of the following best explains the mechanism of his improvement?
Correct Answer
C) Reduced heart rate and contractility, which lower oxygen demand while lengthening diastolic coronary filling time
Rationale
Beta-1 blockade lowers heart rate and contractility, reducing myocardial oxygen demand. The slower heart rate also lengthens the diastolic interval, increasing the time available for coronary filling, which together address both sides of the supply-demand balance.
Question 16
A 57-year-old woman with stable angina and a history of mild persistent asthma needs to start a beta-blocker. Her physician chooses a cardioselective agent at a low starting dose rather than a non-selective agent. Which of the following best explains the mechanism behind this choice?
Correct Answer
A) Non-selective agents block beta-2 receptors in bronchial smooth muscle, which can provoke bronchoconstriction
Rationale
Non-selective beta-blockers block beta-2 receptors along with beta-1 receptors, and beta-2 blockade in bronchial smooth muscle can provoke bronchoconstriction. A cardioselective agent at a low starting dose reduces, though does not eliminate, this risk in a patient with active bronchospastic disease.
Question 17
A 46-year-old woman has recurrent chest pain at rest, predominantly in the early morning, with transient ST-segment elevation on electrocardiogram during episodes. She is started on a beta-blocker for presumed stable angina, and her symptoms become more frequent and severe. Which of the following best explains why the beta-blocker worsened her condition?
Correct Answer
D) Beta-2 blockade removed a normal coronary vasodilatory influence, leaving alpha-1-mediated vasoconstriction unopposed
Rationale
This presentation describes vasospastic angina, in which beta-blockers are contraindicated. Beta-2 blockade removes a normal coronary vasodilatory influence, leaving alpha-1-mediated vasoconstriction unopposed and worsening the underlying spasm. This effect applies to all beta-blockers, including cardioselective agents.
Question 18
A 68-year-old man with coronary artery disease has been taking metoprolol for two years. He runs out of his medication while traveling and goes five days without a dose. He develops chest pain, palpitations, and a resting heart rate of 118 beats per minute. Which of the following best explains this presentation?
Correct Answer
B) Chronic blockade had caused beta-receptor upregulation, and the abruptly unblocked, more sensitive receptors were exposed to normal catecholamines
Rationale
Chronic beta-receptor blockade causes compensatory upregulation in the number and sensitivity of beta-adrenergic receptors. Abrupt discontinuation suddenly exposes this enlarged, more sensitive receptor population to normal circulating catecholamines, producing rebound tachycardia, hypertension, and an increased risk of rebound angina that can be more severe than baseline symptoms.